The Intra-Aortic Balloon Pumps Insertion Registry on Behalf of the Groupe Des Angioplasticiens de la Région Ouest
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Interventional Cardiology
- Sponsor
- Rennes University Hospital
- Enrollment
- 177
- Locations
- 25
- Primary Endpoint
- IABP insertion rate
- Last Updated
- 8 years ago
Overview
Brief Summary
Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males and females at least of 18 of age;
- •Undergoing IABP treatment ;
- •Subject, relatives or legal guardian signified their non-opposition to participate in the study
Exclusion Criteria
- •IABP insertion in immediate post-intervention period
Outcomes
Primary Outcomes
IABP insertion rate
Time Frame: 1 year
Secondary Outcomes
- Number of cardiogenic shock(1 year)
- Number of mechanical complication of acute coronary syndrome(1 year)
- Number of myocardial infarction not shocked(1 year)
- Number of other indications(1 year)
- Survival rate following IABP insertion(1 year)
- IABP-related complications rate and type(1 year)